Drug Clinical Trials List

Share page

Display 671 - 680 from 730
Study Title Study Sponsor Status Study Drug Trial Phase Study Protocol Number Site
Early Goal Directed Sedation vs. Standard Care Sedation The Australian and New Zealand Intensive Care Research Centre, Monash University, Australia Ongoing Dexmedetomidine 4 YS/003 King Saud Medical City (Riyadh)
Efficacy of Different Mouthwashes in the Reduction of Halitosis: A Randomized, Double Blind, Placebo-Controlled, Crossover Clinical Trial King Abdulaziz City for Science and Technology (KACST) Ongoing Halita - AO ProRinse 4 PR oo39 College of Dentistry King Saud University
easypod connect: A regional, Multicentre, Observational study to evaluate Adherenceand Long Term Outcomes of Therapy in Paediatric subjects using “easypodTM” electromechanical device for growth hormone treatment Merck Serono Ongoing N/A 4 EMR200104-534 King Fahad University Hospital (Al-Khobar), alhabib
Observational Prospective STudy In Management of 1st line KRAS Wildtype mCRC with Erbitux™ (Cetuximab)- OPTIM1SE Merck Serono Ongoing Erbitux (Cetuximab) 4 EMR062202-561 King Fahad Medical City (Riyadh), King Abdulaziz Medical City NG (Riyadh), Prince Sultan Military Medical City (Riyadh), King Fahad Specialist Hospital (Dammam)
Postoperative Analgesic Effect ofDexmedetomidine as an Adjunct to Ropivacaine Administration in Wound Infiltration for Modified Radical Mastectomy- A Randomized controlled Trial King Abdullah Medical City, Makkah Ongoing DEXMEDETOMIDINE 2 14-119 King Abdullah Medical City (Makkah)
AWARE-AMAC (A World-wide Antihistamine-Refractory chronic urticaria patient Evaluation in Asia pacific, Middle-east and African Countries (AWARE-AMAC): A noninterventional study to collect data on the management and clinical impacts of chronic urticaria in patients refractory to H1-antihistamine therapy Novartis Ongoing N/A 4 E3401 King Abdulaziz University Hospital (Jeddah), King Fahad Specialist Hospital (Dammam), King Faisal Specialist Hospital and Research Center (Riyadh), King Faisal Specialist Hospital and Research Center (Jeddah)
Non transfusion dependent Thalassemia Drug Registry Novartis Ongoing Exjade (Deferasirox) 4 E2422 King Abdulaziz University Hospital (Jeddah), King Abdulaziz Medical City NG (Jeddah), King Khalid University Hospital (Riyadh)
CogniPlus Study assessing Cognitive performance plus Physical activity in patients with Relapsing-Remitting MS under treatment with Betaferon® Bayer Ongoing Betaferon 4 16036 King Fahad Hospital (Madinah), Security Forces Hospital (Riyadh), Aseer Central Hospital, King Khalid University Hospital (Riyadh), Al-Noor Specialist Hospital (Makkah), King Abdul Aziz Specialist hospital (Taif), King Fahad Specialist Hospital (Dammam)
International Registry to assess mEdical Practice withlOngitudinal obseRvation for Treatment of Heart Failure(REPORT-HF) Novartis Ongoing N/A 4 2401 King Fahad Specialist Hospital (Dammam)
A Phase III randomized, double-blind, placebo-controlled study of LEE011 or placebo in combination with tamoxifen and goserelin or a non-steroidal aromatase inhibitor (NSAI) and goserelin for the treatment of premenopausal women with hormone receptor positive, HER2-negative, advanced breast cancer Novartis Ongoing LEE011 (Ribociclib) 3 CLEE011E2301 King Khalid University Hospital (Riyadh)_ King Faisal Specialist Hospital and Research Center (Riyadh)


هل استفدت من ما هو مقدم في هذه الصفحة؟
0 من الزوار ردوا بنعم من أصل0 مشاركة
السبب
السبب